We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+52.12%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$1.06B
Cap. Flow
+$1.07B
Cap. Flow %
41.35%
Top 10 Hldgs %
67.03%
Holding
812
New
224
Increased
195
Reduced
131
Closed
143

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$211M
2
NVDA icon
NVIDIA
NVDA
+$146M
3
META icon
Meta Platforms (Facebook)
META
+$111M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$42.4M
5
AAPL icon
Apple
AAPL
+$35.7M

Sector Composition

Rank Sector Weight
1 Financials 29.84%
2 Technology 29.38%
3 Healthcare 23.72%
4 Communication Services 6.1%
5 Energy 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARIZW
776
DELISTED
Arisz Acquisition Corp. Warrant
ARIZW
-147,029
Closed -$14.7K
WRAC
777
DELISTED
Williams Rowland Acquisition Corp.
WRAC
-79,364
Closed -$832K
SZZLW
778
DELISTED
Sizzle Acquisition Corp. Warrant
SZZLW
-42,084
Closed -$3.79K
LCAHW
779
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
-165,000
Closed -$10.7K
ACAHW
780
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
-784,937
Closed -$19.6K
LCAA
781
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
-1,049,264
Closed -$11.3M
SHAP.WS
782
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
-145,480
Closed -$4.36K
LCAAW
783
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
-92,950
Closed -$62.3K
VHAQ
784
DELISTED
Viveon Health Acquisition Corp.
VHAQ
-12,259
Closed -$138K
VHAQ.RT
785
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
-526,475
Closed -$31.6K
CHEA
786
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
-17,693
Closed -$195K
NRAC
787
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
-76,775
Closed -$837K
NRACW
788
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
-183,556
Closed -$1.87K
IMGN
789
DELISTED
Immunogen Inc
IMGN
-131,099
Closed -$3.89M
HHLA.WS
790
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
-500,000
Closed -$12.5K
HHLA
791
DELISTED
HH&L Acquisition Co.
HHLA
-135,000
Closed -$1.44M
NUBIW
792
DELISTED
Nubia Brand International Corp. Warrant
NUBIW
-70,710
Closed -$3.32K
DMAQR
793
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
-553,167
Closed -$166K
OPA
794
DELISTED
Magnum Opus Acquisition Limited
OPA
-299,721
Closed -$3.23M
OPA.WS
795
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
-369,415
Closed -$6.24K
NCACW
796
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
-53,900
Closed -$862
OTECW
797
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
-602,103
Closed -$14.1K
MRTX
798
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-123,783
Closed -$7.27M
GSDWW
799
DELISTED
Global Systems Dynamics, Inc. Warrant
GSDWW
-46,782
Closed -$219
ATAKR
800
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
-259,362
Closed -$48K

Similar funds

Cowen and Company's Q1 2024 Portfolio in Review

As of Q1 2024, Cowen and Company held 812 positions worth $2.58B, up 69% from $1.52B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $1.07B of net new capital in Q1 2024, opening 224 new positions and adding to 195 existing holdings. Its largest new stake was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, an estimated $30.3M trimmed.

  • Cowen and Company's largest Q1 2024 buy was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.
  • Cowen and Company added most to Coinbase in Q1 2024, an estimated $211M increase.
  • Cowen and Company's biggest Q1 2024 reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, cutting an estimated $30.3M.
  • Cowen and Company fully exited State Street Energy Select Sector SPDR ETF in Q1 2024, selling an estimated $33M.
  • Cowen and Company's ten largest holdings make up 67% of its $2.58B portfolio in Q1 2024.
  • Cowen and Company opened 224 new positions and closed 143 in Q1 2024.
  • Cowen and Company's portfolio value rose 69% quarter-over-quarter to $2.58B.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.